Sonoma Pharma: Rises after Q1 revenue surges 66%

Sonoma Pharmaceuticals

17/08/2020 13:14

** Specialty pharmaceutical company's shares  SNOA.O  rise
18% to $8.89 premarket after co posts a 66% rise in Q1 revenue
    ** Says quarter was helped by coronavirus-driven demand for
virucidal and disinfectant technology  urn:newsml:reuters.com:*:nBw8BGRyTa
    ** Q1 operating expenses were down 32% to $2.8 mln vs last
year 
    ** We've transitioned most of our California manufacturing
to our existing factory in Mexico and are beginning to see the
cost savings from those actions- CEO Amy Trombly says 
    ** Stock has surged ~73% YTD

 (Reporting by Shreyasee Raj in Bengaluru)
 ((Shreyasee.Raj@thomsonreuters.com;))